We work for one of the greatest industries on earth, an industry that looks after the most fundamental of human needs.
We work for one of the greatest industries on earth, an industry that looks after the most fundamental of human needs. Somehow we have lost track of the magnitude of what we do whilst we try and keep the city happy? Surely what we do is care
Whilst I am suggesting the industry should turned into a charity, voices are getting louder that are saying we are an industry for the elderly that is funded by the elderly. They may ask for different returns on their investment in the future. Imagine how excited the public are about me too products.
In the end, we save oor improve lives and questions are being asked if our current business model fits what we do. can we behave like our colleagues in the financial institutions? or do we have to operate differently given what we do. I think the industry will go through more change in the coming decade than the prior one
blog comments powered by DisqusKevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs